| Sunitinib studied in …STUDIED_INderived200 of 387show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · 387 trials list this drug (33 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Lymphoma,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218926Phase 3 · recruiting A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy · 387 trials list this drug (33 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05773274Phase 2 · recruiting Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial · 387 trials list this drug (33 active) | — | — | Digestive System Neuroendocrine Tumor G1,Digestive System Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899155Phase 2 · recruiting Pan Tumor Rollover Study · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02693535Phase 2 · recruiting TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer · 387 trials list this drug (33 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05687123Phase 1 · recruiting Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors · 387 trials list this drug (33 active) | — | — | Pancreatic Neoplasm,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03900793Phase 1 · recruiting Losartan + Sunitinib in Treatment of Osteosarcoma · 387 trials list this drug (33 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01216371Phase 2 · terminated Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141177Phase 3 · completed A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396408Phase 2 · active not recruiting A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours · 387 trials list this drug (33 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03463460Phase 2 · active not recruiting Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer · 387 trials list this drug (33 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678673Phase 3 · active not recruiting Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03768063Phase 3 · active not recruiting A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390826Phase 2 · active not recruiting Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V) · 387 trials list this drug (33 active) | — | — | Lymphoma,Malignant Solid Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03091192Phase 3 · active not recruiting Savolitinib vs. Sunitinib in MET-driven PRCC. · 387 trials list this drug (33 active) | — | — | Neoplasm by Site,Carcinoma,Urinary Tract Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06948955available Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors · 387 trials list this drug (33 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326898Phase 3 · completed Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery · 387 trials list this drug (33 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00693992Phase 3 · completed Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy · 387 trials list this drug (33 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02848768completed Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453154Phase 1/Phase 2 · completed Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 387 trials list this drug (33 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208047Phase 3 · recruiting (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329043Phase 2 · active not recruiting Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy · 387 trials list this drug (33 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715442Phase 2 · active not recruiting Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02231749Phase 3 · completed Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260894Phase 3 · completed Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043090Phase 3 · active not recruiting Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC · 387 trials list this drug (33 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00510640Phase 2 · completed Thyroid Cancer and Sunitinib · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814021Phase 2 · completed Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04633122Phase 2 · completed A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555748Phase 4 · completed Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05477576Phase 3 · recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy · 387 trials list this drug (33 active) | — | — | Digestive System Neuroendocrine Tumor,Neuroendocrine Tumor,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297606Phase 2 · recruiting Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) · 387 trials list this drug (33 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024214Phase 1/Phase 2 · recruiting Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors · 387 trials list this drug (33 active) | — | — | Solid Neoplasm,Hepatocellular Carcinoma,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07477457Phase 2 · recruiting A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma · 387 trials list this drug (33 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068586Phase 2 · active not recruiting Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma · 387 trials list this drug (33 active) | — | — | Uveal Melanoma,Iris Melanoma,Medium/Large Size Posterior Uveal Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811861Phase 3 · active not recruiting Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03673501Phase 3 · active not recruiting A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01391962Phase 2 · completed Sunitinib or Cediranib for Alveolar Soft Part Sarcoma · 387 trials list this drug (33 active) | — | — | Alveolar Soft Part Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02853331Phase 3 · completed Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245968Phase 1 · active not recruiting A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734105Phase 3 · active not recruiting A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04394975Phase 3 · completed Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165418Phase 3 · not yet recruiting A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05366816Phase 2 · recruiting ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684006Phase 3 · completed A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01286896Phase 1 · completed Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors · 387 trials list this drug (33 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00437372Phase 1 · completed Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,Nervous System Neoplasm,Thoracic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940349Phase 1/Phase 2 · recruiting Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02230176Phase 2 · completed Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II · 387 trials list this drug (33 active) | — | — | Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720941Phase 3 · completed Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381641Phase 2 · completed Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery · 387 trials list this drug (33 active) | — | — | Thyroid Gland Follicular Carcinoma,Thyroid Gland Oncocytic Carcinoma,Thyroid Gland Medullary Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01147822Phase 2 · completed Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02401815Phase 1/Phase 2 · completed CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254864Phase 2 · completed Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies · 387 trials list this drug (33 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761057Phase 2 · completed Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed · 387 trials list this drug (33 active) | — | — | Papillary Renal Cell Carcinoma,Renal Cell Carcinoma,Type 1 Papillary Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00843037Phase 2 · completed Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma · 387 trials list this drug (33 active) | — | — | Paraganglioma,Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04523272Phase 3 · active not recruiting A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03109015Phase 2 · completed Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306045Phase 2 · completed Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies · 387 trials list this drug (33 active) | — | — | Thymus Carcinoma,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01621568Phase 2 · completed Sunitinib for Advanced Thymus Cancer Following Earlier Treatment · 387 trials list this drug (33 active) | — | — | Thymus Neoplasm,Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700258completed Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] · 387 trials list this drug (33 active) | — | — | Carcinoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05745142completed A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine. · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04669366completed Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries · 387 trials list this drug (33 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00330564Phase 2 · terminated Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow · 387 trials list this drug (33 active) | — | — | Hemangioblastoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905889Phase 1 · terminated A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282059completed The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors · 387 trials list this drug (33 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03140176terminated Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy. · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 387 trials list this drug (33 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482755Phase 2 · completed Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery · 387 trials list this drug (33 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04409223Phase 3 · terminated Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 387 trials list this drug (33 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949424Phase 4 · unknown OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults · 387 trials list this drug (33 active) | — | — | Breast Carcinoma,Ovarian Carcinoma,Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02483247Phase 1 · completed A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01934452completed Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264665completed OPALINE : A Study Of Morbidity And Mortality At 2 Years · 387 trials list this drug (33 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01517243Phase 2 · completed Phase II Study of Alternating Sunitinib and Temsirolimus · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06032728NA · not yet recruiting Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00813423Phase 1 · completed Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy · 387 trials list this drug (33 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164228Phase 2 · completed Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery · 387 trials list this drug (33 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00716625completed Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175262completed Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03729245Phase 3 · terminated A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00716820completed Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan). · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04033991completed Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. · 387 trials list this drug (33 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04076787completed Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420821Phase 3 · completed A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520533Phase 1 · terminated Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981890Phase 1 · completed Stereotactic Radiosurgery With Sunitinib for Brain Metastases · 387 trials list this drug (33 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936832Phase 2 · withdrawn Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02432846Phase 2 · completed Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01061411Phase 1 · completed Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery · 387 trials list this drug (33 active) | — | — | Clear Cell Sarcoma of the Kidney,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371201Phase 2 · completed First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma · 387 trials list this drug (33 active) | — | — | Paraganglioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02450123NA · completed Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors · 387 trials list this drug (33 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02691793Phase 4 · completed Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors · 387 trials list this drug (33 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170180Phase 2 · completed Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer · 387 trials list this drug (33 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · 387 trials list this drug (33 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115189completed A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641326Phase 2 · terminated Sunitinib in Sarcomas of the Central Nervous System · 387 trials list this drug (33 active) | — | — | Central Nervous System Sarcoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164202Phase 2/Phase 3 · completed Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer · 387 trials list this drug (33 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035630Phase 2 · withdrawn Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Kidney Neoplasm,Malignant Kidney Neoplasm,Clear Cell Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00698815Phase 2 · completed Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer · 387 trials list this drug (33 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01308034Phase 1 · completed Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01472081Phase 1 · completed Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689167Phase 2 · unknown Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00695292Phase 2 · completed Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer · 387 trials list this drug (33 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01620216Phase 2 · terminated Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia · 387 trials list this drug (33 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02959554Phase 2 · terminated Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01024920Phase 2 · completed Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib. · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164240Phase 1 · completed Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449173Phase 2 · unknown Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) · 387 trials list this drug (33 active) | — | — | Thymoma,Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01185366Phase 2 · terminated Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00853125Phase 2 · terminated Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960906Phase 2 · completed A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025893Phase 2/Phase 3 · unknown A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme · 387 trials list this drug (33 active) | — | — | Glioblastoma,Adult Glioblastoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636908NA · completed Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies. · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541008Phase 2 · completed Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer · 387 trials list this drug (33 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835158Phase 2 · completed Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Clear Cell Renal Cell Carcinoma,Kidney Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04368546completed Sunitinib Treatment on Tissue Sodium Accumulation (TSS2) · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01694277Phase 3 · completed Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03066427Phase 2 · completed Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03909724Phase 2/Phase 3 · unknown Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) · 387 trials list this drug (33 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01673386Phase 2 · terminated A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02239952NA · unknown HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02315625Phase 2 · terminated Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery · 387 trials list this drug (33 active) | — | — | Neuroendocrine Neoplasm,Neuroendocrine Carcinoma,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005472Phase 1 · completed Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma · 387 trials list this drug (33 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00905021Phase 1/Phase 2 · terminated Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer · 387 trials list this drug (33 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00853372Phase 2 · completed AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00543504Phase 1 · completed Bevacizumab in Multiple Phase I Combinations · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02779283Phase 1 · completed Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia · 387 trials list this drug (33 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02713763Phase 2 · completed Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02060370Phase 2 · completed Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) · 387 trials list this drug (33 active) | — | — | Malignant Genitourinary System Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00783653Phase 1/Phase 2 · completed Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years · 387 trials list this drug (33 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979992Phase 2 · completed Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer · 387 trials list this drug (33 active) | — | — | Ovarian Carcinoma,Ovarian Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478426Phase 2 · completed Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · 387 trials list this drug (33 active) | — | — | Uterine Corpus Carcinosarcoma,Endometrial Adenocarcinoma,Endometrial Endometrioid Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03571438NA · unknown Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors · 387 trials list this drug (33 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00616122Phase 1/Phase 2 · terminated Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer · 387 trials list this drug (33 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01984242Phase 2 · completed A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00975806Phase 1/Phase 2 · terminated Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00859456Phase 2 · terminated Sunitinib in Certain Subtypes of Soft Tissue Sarcomas · 387 trials list this drug (33 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01551459Phase 2 · completed A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma · 387 trials list this drug (33 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00709995Phase 2 · completed A Study for Participants With Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00794950Phase 2 · completed Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma · 387 trials list this drug (33 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408252Phase 2 · terminated Efficacy of SU 011248 in Head And Neck Carcinoma · 387 trials list this drug (33 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03519542completed Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03592199Phase 2 · unknown Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib · 387 trials list this drug (33 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513695Phase 2 · completed Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer · 387 trials list this drug (33 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01525550Phase 4 · completed A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378911Phase 2 · completed Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus · 387 trials list this drug (33 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01391130Phase 2 · terminated A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02058901Phase 1 · completed Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors. · 387 trials list this drug (33 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00428220NA · completed A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. · 387 trials list this drug (33 active) | — | — | Malignant Breast Neoplasm,Gastrointestinal Stromal Tumor,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026337completed Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01118351Phase 2 · terminated Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer · 387 trials list this drug (33 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00526656Phase 2 · completed Sunitinib in Treating Patients With Locally Advanced Bladder Cancer · 387 trials list this drug (33 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396148Phase 2 · completed A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502228NA · terminated PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862768NA · unknown Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment · 387 trials list this drug (33 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453895Phase 2 · completed Sunitinib in Refractory Adrenocortical Carcinoma · 387 trials list this drug (33 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02623127Phase 2 · completed A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma · 387 trials list this drug (33 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258348Phase 1 · completed A Phase 1b Trial in Patients With Renal Cell Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03323710Phase 2 · withdrawn Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506336Phase 2 · completed Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01740154NA · terminated Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01829217Phase 2 · completed Sunitinib in Never-Smokers With Lung Adenocarcinoma · 387 trials list this drug (33 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01089088Phase 2 · completed Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) · 387 trials list this drug (33 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00599313Phase 2 · completed Phase II Sunitinib Prog Met AIPC · 387 trials list this drug (33 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00864721Phase 2 · completed Sunitinib Non Small Cell Lung Cancer Patients Over 70 · 387 trials list this drug (33 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560012Phase 2 · terminated Personalized Targeted Inhibitors Treatment in Renal Cell Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375674Phase 3 · completed A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer · 387 trials list this drug (33 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158222Phase 2 · completed Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00451048Phase 2 · completed Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · 387 trials list this drug (33 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00768144Phase 2 · completed Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma · 387 trials list this drug (33 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00578526Phase 2 · completed SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial · 387 trials list this drug (33 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02919371Phase 1/Phase 2 · unknown Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00748163Phase 2 · withdrawn Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer · 387 trials list this drug (33 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00953459Phase 2 · terminated Sunitinib Malate in Treating Patients With Small Cell Lung Cancer · 387 trials list this drug (33 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00891878Phase 2 · completed Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction · 387 trials list this drug (33 active) | — | — | Malignant Esophageal Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03275558Phase 1 · withdrawn Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma · 387 trials list this drug (33 active) | — | — | Glioblastoma,Glioma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00463060Phase 1/Phase 2 · completed Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer · 387 trials list this drug (33 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01824615Phase 2 · completed Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626754Phase 2 · terminated A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01829841Phase 2 · completed A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00824538Phase 2 · terminated Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow · 387 trials list this drug (33 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01402817Phase 2 · terminated Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01499121Phase 2 · completed Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule · 387 trials list this drug (33 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01108445Phase 2 · completed Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01265901Phase 3 · completed IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499135Phase 1 · completed Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors · 387 trials list this drug (33 active) | — | — | Adult Solid Neoplasm,Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01784978Phase 2 · terminated Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498835Phase 1 · completed Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma · 387 trials list this drug (33 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042795Phase 2 · terminated Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy · 387 trials list this drug (33 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00537056NA · completed Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI · 387 trials list this drug (33 active) | — | — | Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787787Phase 2 · terminated Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer · 387 trials list this drug (33 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00524316Phase 2 · terminated Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · 387 trials list this drug (33 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400114Phase 2 · completed Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer · 387 trials list this drug (33 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425386Phase 2 · completed Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519896Phase 2 · completed Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer · 387 trials list this drug (33 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Medullary Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064310Phase 3 · completed Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02071641Phase 2 · terminated Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma · 387 trials list this drug (33 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |